StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $5.62 | $6.22 | +10.68% | 9.8M |
| 05-12 | $5.99 | $5.97 | -0.33% | 5.2M |
| 05-13 | $6.00 | $6.32 | +5.33% | 6.3M |
| 05-14 | $6.22 | $6.09 | -2.17% | 4.0M |
| 05-15 | $5.79 | $5.80 | +0.26% | 1.2M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $23.85M | $7.19M | $2.30M | $1.10M |
Operating Income | $-59.91M | $-34.89M | $-19.92M | $-7.95M |
Net Income | $-159.84M | $-96.51M | $-75.16M | $-8.46M |
EPS (Diluted) | $-2.11 | $-1.27 | $-1.17 | $-0.12 |
Total Assets | $498.02M | $225.89M | $135.91M | $90.87M |
Total Liabilities | $235.12M | $129.29M | $107.60M | $45.15M |
Cash & Equivalents | $285.60M | $113.90M | $67.70M | $56.00M |
Free Cash Flow OCF − CapEx | $-47.43M | $-27.18M | $-15.18M | $-5.48M |
Shares Outstanding | 111.68M | 93.38M | 83.91M | 72.07M |
No sell-side coverage available for ASPI.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for ASPI.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.